Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.670
+0.030 (1.14%)
Nov 20, 2024, 4:00 PM EST - Market closed
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $7.59 million as of November 21, 2024. Its market cap has decreased by -53.97% in one year.
Market Cap
7.59M
Enterprise Value
-1.30M
1-Year Change
-53.97%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $7.59M, a decrease of -89.26%. That is a compound annual growth rate of -23.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 8.00M | -68.75% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syros Pharmaceuticals | 7.77M |
| Mustang Bio | 7.77M |
| Ontrak | 7.72M |
| Coeptis Therapeutics Holdings | 7.69M |
| Galecto | 7.65M |
| Cardio Diagnostics Holdings | 7.47M |
| Evoke Pharma | 7.26M |
| Edesa Biotech | 7.14M |